Phase 1a safety and pharmacokinetic study of oral NV-196 in patients with solid tumours
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Triphendiol (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors MEI Pharma; Novogen
- 26 May 2008 New trial record.
- 15 May 2008 Results will be reported at the 44th Annual Meeting of the American Society of Clinical Oncology.